Fractional CMOMarketing + TechnologySoftware developmentCybersecurityAI automationPricingResultsAboutInsightsCMO DailyBook a Free Strategy Call →More: ServicesPortfolioAppsAcademy
Healthcare · Digital health · Medical devices

Fractional CMO for Healthcare and Health Tech Companies

Mark GabrielliBy Mark Gabrielli · Fractional CMO & COO · Last updated: May 2026

Your product works and your pilots prove it. The problem is turning a few champions into signed enterprise contracts while every claim you publish has to survive legal review and every buyer has three bosses.

Short answer

A fractional CMO for a healthcare company owns go-to-market part time: which settings to sell into, what you can safely claim, and a demand engine that reaches the clinical champion, the finance team and IT security in the same quarter. Most engagements cost $5,000 to $20,000 a month, and the first 30 days are a diagnostic, not a campaign.

Book a Free Strategy Call30 minutes with Mark. No pitch, no obligation.

If you are weighing senior marketing leadership, start with what a fractional CMO does, what one costs and when to hire one instead of a full-time CMO or an agency.

When healthcare companies bring in a fractional CMO

The call usually starts with one of these situations:

  • Pilots that never convert. Two or three sites love the product, but there is no repeatable way to reach the next twenty.
  • A clinician founder who is still the only closer. Physicians trust a physician, so every deal waits on one calendar.
  • An agency that bought traffic, not meetings. Sometimes it also produced a claim that compliance had to pull back.
  • A board asking for enterprise growth while the team is still selling one practice at a time.

Why the standard B2B playbook breaks in healthcare

Not sure a fractional CMO is the right move?

Take the 60-second fit check →Free, no obligation. If it's a fit, you'll pick a time to talk with Mark directly.

A hospital purchase is a committee decision. The clinical champion wants outcomes, the value analysis committee wants cost evidence, IT wants a security review and a business associate agreement, and the CFO wants payback. Marketing that speaks to one of them stalls with the other three.

Claims are also constrained. A device can only be promoted for its cleared indications, outcome claims need evidence you can hand to a skeptical reviewer, and tracking pixels on patient-facing pages are now a privacy question, not just an analytics one. The job is to market hard inside those lines, with your regulatory counsel in the loop, rather than pretend they are not there.

What Mark brings to a healthcare engagement

Mark Gabrielli is a Certified Surgical Technologist (2012) who worked the instrument table across six surgical specialties, including cardiovascular and orthopedic surgery. He has held HIPAA responsibility at the CMO level for a healthcare AI platform. He knows how clinicians judge a vendor because he has stood in the room where the product gets used.

Healthcare SaaS, $4M ARR at the start: grew to $16M ARR in 18 months. The ICP was rebuilt around hospital groups instead of individual practices, an account-based program targeted 120 named health systems, and EHR integration partners became 30% of new ARR.

Digital health platform: 3x pipeline in six months with zero compliance issues, after a previous agency had produced no pipeline and a compliance flag. First enterprise contract signed in month seven.

Sources: MarkCMO case studies and results. Client names are kept confidential.

Your first 90 days

WindowWhat happensWhat you have at the end
Days 1 to 30Claims inventory with your regulatory lead, ICP by care setting, buying-committee map, audit of tracking on patient-facing pages, review of every channel you pay for.An approved claims list, a ranked target list and a stop-doing list.
Days 31 to 60Evidence library (outcomes, case studies, an ROI model a value analysis committee can use), messaging for each stakeholder, partner and marketplace review.Sales assets for every seat at the table.
Days 61 to 90Named-account program live, conference and specialty-society plan, weekly pipeline review with sales.Meetings with economic buyers and a forecast you can defend.

See what your first 90 days would look like

Bring your current pipeline and your toughest compliance constraint. You will leave with the first two things to fix, whether or not we work together.

Book a free 30-minute strategy call

The numbers we manage in healthcare

MetricWhy it matters here
Committee coverageAccounts where you have engaged clinical, finance and IT contacts, not just a champion.
Pilot to contract rateThe clearest sign that proof is landing with the people who sign.
Sales cycle by settingHealth systems, ambulatory groups and practices move at very different speeds.
Security review timeA slow questionnaire quietly kills quarters. Marketing can pre-answer it.
Pipeline by sourceShows whether partners, events or content actually create meetings.

What it costs

Most fractional CMO engagements cost $2,500 to $50,000 a month (most $8,000 to $15,000), and lighter early-stage scopes start at $2,500. The full breakdown is on our fractional CMO cost guide. A full-time healthcare CMO adds salary, equity and a long search before any of the work starts.

What healthcare founders ask before they book

"Our market is too regulated for real marketing." It is regulated, not closed. The companies that win publish more evidence, not less, and they get it approved before launch instead of after.

"We need someone full time." Maybe later. A fractional CMO builds the system and the team first, then helps you hire the right full-time leader when the engine justifies it.

Healthcare fractional CMO FAQ

What does a fractional CMO do for a healthcare company?

A fractional CMO leads your go-to-market part time. That means choosing the care settings and accounts to pursue, building messaging for each member of the buying committee, keeping claims inside regulatory limits with your counsel, and running the programs that create meetings: account-based outreach, evidence content, partners and events. You get executive ownership of pipeline without a full-time executive salary.

How much does a fractional CMO cost for a healthcare company?

Most fractional CMO engagements cost $2,500 to $50,000 a month (most $8,000 to $15,000), depending on scope and time. Lighter early-stage scopes run $3,000 to $6,000 a month. Healthcare work often sits in the middle of the range because claims review and multi-stakeholder selling add work. See the cost guide for the full breakdown.

Can a fractional CMO keep our marketing HIPAA and FDA compliant?

A fractional CMO designs marketing to work inside HIPAA, FDA and FTC limits, for example by building an approved claims list, keeping promotion to cleared indications and auditing tracking on patient-facing pages. That is not a substitute for legal review. The right setup is your regulatory counsel approving claims and the CMO building a program that does not need constant rescue.

How long until a healthcare company sees results?

Expect the first 30 days to be diagnostic work, with early pipeline signals between days 60 and 90 as named-account outreach and evidence content go live. Signed enterprise contracts follow your sales cycle, which is often several months longer. In one digital health engagement the pipeline tripled within six months and the first enterprise contract was signed in month seven.

Talk to a CMO who has worked inside healthcare

Tell Mark where deals stall today. In 30 minutes you will know whether the problem is targeting, proof, compliance or follow-through, and what to do about it first.

Book a Free Strategy Call
Mark Gabrielli speaking under stage lights

Talk it through with the fractional CMO who runs it.

See if Mark has availability for a call

Free. 30 minutes. With Mark, not a salesperson.

Health tech, medical devices and medical practices need three different plans

A fractional CMO for healthcare starts by naming which of three businesses you are, because a health tech platform, a medical device maker and a physician practice share a label and almost nothing else. The buyer, the proof, the channel that books meetings and the compliance line all change. When healthcare marketing stalls, the plan was often borrowed from the wrong one of the three.

SegmentWho signsProof they needWhat creates meetingsThe line you cannot cross
Health tech sold to providersA committee: clinical champion, value analysis, IT security, CFOOutcome data from comparable sites and an ROI model finance can auditNamed-account outreach, EHR marketplace listings, integration partnersOutcome claims you cannot back with evidence; patient data in ad tracking
Medical devicesSurgeons and department chiefs, then supply chain and the GPO contractClinical evidence, training and proctoring, a cleared indicationSpecialty society meetings, surgeon champions, distributor or direct repsPromotion outside cleared indications; calling a 510(k) device "FDA approved"
Medical practices and physician groupsThe patient, then the referring physicianReviews, access, clear pricing where it applies, a credible physicianLocal search, the Google Business Profile, physician-to-physician referral relationshipsConfirming a patient relationship in review replies; paying for referrals

Health tech: selling to a health system

For health tech, the marketing job is getting through procurement, not just reaching a champion. Expect a security questionnaire, a business associate agreement, vendor credentialing and, in many systems, a group purchasing organization or integrated delivery network contract in the path. Listing in the EHR marketplace your customers already use, such as Epic Showroom, and pre-answering the security review on your website shortens quarters that would otherwise disappear in a queue. Content should be written for the value analysis committee as well as the clinician, because the committee is where many pilots stall.

Medical devices: evidence, surgeons and the cleared claim

Device marketing is built on the exact wording of your clearance. A 510(k) device is cleared, not approved, and promotion has to stay inside the indications on file, so the first deliverable is an approved claims list your regulatory lead signs. From there the engine is surgeon champions, data presented at the specialty society meetings your buyers attend, and a rep model, distributor or direct, matched to your margin and territory. Marketing also has to arm the reps for the supply chain conversation, because a surgeon who wants the device still needs the hospital to contract for it.

Medical practices: patients first, referrals second

For a practice, marketing leadership means owning patient demand in a few neighborhoods. That is local search, a complete Google Business Profile, a steady flow of genuine reviews, and a booking path that works on a phone at 9 p.m. Reply to reviews without confirming that the reviewer is a patient, since the HHS Office for Civil Rights has penalized practices for disclosing patient details in replies. Referral growth comes from relationships and fast communication with referring physicians, never from paying for referrals, which federal and state law restrict. Testimonials must be real and typical, under the FTC rules on endorsements and reviews.

What changes when a fractional CMO markets a medical device company?

The claims list comes before the campaign. A fractional CMO working with a device company first agrees an approved claims list with the regulatory lead, built on the cleared indications, then builds the program around surgeon champions, clinical evidence and the specialty meetings buyers attend. Sales enablement covers the supply chain and GPO conversation as well as the clinical one. The goal is more surgeons asking for the device, inside language that will survive review, rather than reach that creates a compliance problem later.

Can a fractional CMO help a medical practice or physician group?

Yes, when the practice has more than one location or a growth goal beyond word of mouth. The work is patient acquisition in specific neighborhoods: local search, the Google Business Profile, review volume and replies that protect privacy, a booking flow that converts on mobile, and a referral program built on relationships rather than payments. A single small office usually needs a good agency more than a CMO; a group adding sites or service lines needs someone to own the plan and the numbers.

For pricing see the fractional CMO cost guide. Related reading: the fractional CMO services hub, fractional CMO for SaaS, fractional CMO for AI and machine learning companies and fractional CMO for cybersecurity. To pressure test your own plan, book a free strategy call.

Tracking pixels, HIPAA and the health data rules that shape healthcare marketing

A healthcare marketing plan now starts with the measurement setup, because the tools most companies use to track advertising can expose health information. Regulators have focused on exactly this in recent years, and the rules differ depending on whether you are a provider or health plan covered by HIPAA, a consumer health app outside HIPAA, or a company that handles consumer health data in states with their own laws.

RuleWho it reachesWhat it changes in marketing
HIPAA and HHS guidance on online trackingProviders, health plans, and the business associates that work for themHHS issued guidance on tracking technologies in December 2022 and revised it in March 2024. A federal court in Texas vacated part of it in June 2024, the part about public pages that need no login. Pages behind a login, such as patient portals and scheduling, still need care, and any vendor that receives protected health information needs a business associate agreement.
FTC Health Breach Notification RuleHealth apps and personal health record vendors that HIPAA does not coverUpdated in 2024, it treats sharing health data with advertisers without authorization as a breach that must be reported. The FTC brought cases against GoodRx and BetterHelp in 2023 over health data shared for advertising.
State consumer health data lawsCompanies that collect health data from residents, for example under Washington's My Health My Data Act, in effect since March 2024Consent before collecting or sharing consumer health data, and in Washington individuals can sue directly

A measurement setup that holds up

Start with an inventory of every pixel, tag and software kit on the website and app, including the ones an agency added years ago. Keep advertising tags off patient portals, scheduling flows and pages about specific conditions. Send conversion data through a server-side setup that passes only the fields you choose, and use vendors willing to sign a business associate agreement wherever protected information could reach them. Then judge campaigns on aggregated results, such as booked appointments or qualified demos by source, instead of following individual patients across the web.

Your privacy counsel decides what the law requires for your organization. Marketing's job is to design measurement that still shows which spending works without creating that exposure. Health tech companies selling to hospitals should also read the SaaS and cybersecurity pages, since health system buyers review vendor security closely.

Can a healthcare company use advertising pixels on its website?

Sometimes, but not the way most websites install them. A provider or health plan should keep advertising tags off patient portals, scheduling and condition-specific pages, and should not let any vendor receive protected health information without a business associate agreement. Health apps outside HIPAA face the FTC's breach rule and some state laws. The safer pattern is a server-side setup that sends only chosen fields, reviewed by privacy counsel, with campaigns judged on aggregated results.

Who pays decides the healthcare marketing plan

Most healthcare companies that stall have a product clinicians or patients want and a buyer who has not said yes. A fractional CMO for a healthcare company fixes that by naming who pays, who signs and what each of them needs to see, then building marketing that produces exactly that. The user and the buyer are rarely the same person in healthcare, and a plan written for the user alone fills the top of the funnel while deals sit unsigned.

Who paysThe question they askWhat marketing has to produceHow the decision moves
Health system or provider groupWill this improve care or margin without adding work for staff?An ROI model finance can check, workflow proof, answers for the security reviewThrough a committee and the budget year, so timing matters as much as interest
Health plan or payerWill this lower cost or improve quality scores across our members?A population level case, a clear contracting model, outreach that reaches membersThrough clinical, actuarial and contracting reviews; pilots come before full contracts
Self-insured employerWill employees use it, and will it show up in our claims?A member engagement plan, materials for the benefits team, proof for the consultantOften through a benefits consultant or broker, and around the open enrollment calendar
Patient paying directlyIs this worth my money, and can I trust it?Clear pricing, credible clinicians, a booking or checkout path that works on a phoneFast and personal; reviews and search results carry most of the weight

Employers and health plans: market to the people who advise them

Digital health companies selling to employers usually lose time by pitching the HR leader alone. Many employers choose benefits on the advice of a consultant or broker, and they make those choices months before the plan year starts. That makes the consultant a marketing audience in their own right: they need a short, comparable summary of what your program does, who it fits and how you will report engagement. The employer's biggest fear is paying for something employees never open, so the launch plan for members belongs in the sales conversation, not after the signature. Health plans ask a harder version of the same question at population scale, which is why a narrow pilot with clear measures often beats a broad pitch.

Fractional CMO, full-time CMO or agency at each stage

StageWhat the company needsWho should run marketing
Pilots, no repeatable buyer yetProof that one buyer type will pay, and a story the next pilot site believesThe founder, with outside help on positioning and claims
First paying customers in one segmentA repeatable path through procurement, materials for the committee, two working channelsA fractional CMO who owns the plan, with an agency or freelancers doing execution
Growing across segments or service linesSeparate plans for each buyer, a team, a budget that follows resultsA fractional CMO building the team, or the first full-time marketing leader if the work fills a full week
Scale, several product linesA permanent executive who sits on the leadership team every dayA full-time CMO, often hired with the fractional CMO helping to define the role

For the general version of this decision, see when should I hire a fractional CMO.

What a fractional CMO costs a healthcare company

MarkCMO engagements run $2,500 to $50,000 a month, and most fall between $8,000 and $15,000, set by scope and the number of buyer types in the plan. A full-time CMO costs $280,000 to $450,000 a year before benefits, equity and the months a search takes. Work is month to month, so the engagement has to keep earning its place. The full breakdown is in the fractional CMO cost guide.

The first 30 days, week by week

Week 1: the buyer map and the rules. Who pays, who signs and who can stop a deal, by segment. The approved claims list, the tracking inventory and any business associate agreements that measurement depends on.

Week 2: where deals stall. A review of the last year of pipeline to find the stage where healthcare deals die: the security review, the value analysis committee, the budget cycle or the consultant who never heard of you. If leads arrive and go nowhere, this is usually where the answer sits; see why leads do not turn into customers.

Week 3: the plan. Two channels matched to the buyer who pays, a budget, and sales materials written for the committee as well as the champion.

Week 4: launch and the scorecard. The first campaign goes out with measurement that respects health data rules, and a scorecard reports qualified meetings and pipeline by source. For how that reporting should work, see how to find out which marketing is working.

When should a healthcare company hire a fractional CMO?

When the product works but growth depends on a buyer the team has not learned to sell to, such as a health system committee, a health plan or an employer's benefits consultant. Other signs: pilots that never convert to contracts, marketing that produces clinician interest but no signed deals, or a founder still writing every piece of sales material. A fractional CMO sets the plan for the buyer who pays and owns the results, at a fraction of a full-time salary, month to month.

How MarkCMO works with healthcare companies

Mark brings 15 years of marketing leadership and runs every account himself, with no hand-off to a junior team. Engagements are month to month, and first results are targeted in 30 days. More short answers to founder questions are on the answers page. To test your plan against the buyer who actually pays, book a free 30-minute call.

Want a straight read on your marketing?

Book a free 30-minute call with Mark. You will walk away with a clear, honest diagnosis and the one or two things to fix first, whether or not we work together.

Book a free strategy call →
Not sure a fractional CMO is the right move?Take the 60-second fit check →